Why the study?
Does the whole blood rapid troponin T test improve diagnostic specificity for acute coronary syndrome compared to conventional ECG in patients presenting with chest pain?
Does the whole blood rapid troponin T test improve diagnostic specificity for acute coronary syndrome compared to conventional ECG in patients presenting with chest pain?
The rapid troponin T test provides high specificity for diagnosing acute coronary syndrome, complementing the high sensitivity but low specificity of conventional ECG, particularly in non-ST elevation ACS.
Answers are grounded in this paper and cite their sources.
Rapid troponin T may complement ECG for ruling in ACS; hypothesis-generating for combined strategies pending prospective validation.
Emergency triage and therapeutic decisions using the recently developed whole blood rapid troponin T test were evaluated and compared with conventional electrocardiographic (ECG) diagnosis in a total of 155 patients with chest pain who visited 16 emergency outpatient clinics in the Tokyo metropolitan area. Thirty-seven patients (23.9%) had a final diagnosis of acute myocardial infarction or high-risk unstable angina requiring emergency coronary intervention and these events were defined as acute coronary syndrome. Diagnostic values using the second-generation rapid troponin T test were evaluated according to 3 time-windows in 85 patients. The sensitivity of the test was 10% for patients assessed within 3 h after the onset, 62.5% for 3-6 h after, and 75% for more than 6h, whereas conventional ECG diagnosis had 100% sensitivity at any time-window. In contrast, the specificity of the rapid troponin T test was 100%, 100%, and 97.4%, whereas that of conventional ECG diagnosis was 25%, 57.1%, and 42.2%, respectively for the 3 time-windows. The positive predictive value of ECG diagnosis was inferior to the rapid troponin T test, which reflected the prudent attitude of physicians taking ECG decisions as positive when myocardial ischemia was suspected. The diagnostic efficacy of the rapid troponin T test was remarkable in patients with the non-ST elevation type of acute coronary syndrome. A questionnaire survey on therapeutic decisions revealed that only 10% of Tokyo outpatient institutes performed prehospital thrombolytic therapy, 30-33% administered aspirin or nitrate, and 16.7% gave heparin. The rapid troponin T test is extremely useful for cardiac emergency triage and therapeutic decision making. There is a requirement for practical guidelines for the primary therapeutic decisions for patients with suspicious acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: